Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ascendis Pharma A (ASND) Return on Invested Capital: 2015-2025

Historic Return on Invested Capital for Ascendis Pharma A (ASND) over the last 10 years, with Sep 2025 value amounting to 1.43%.

  • Ascendis Pharma A's Return on Invested Capital fell 7.00% to 1.43% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.43%, marking a year-over-year decrease of 7.00%. This contributed to the annual value of -0.47% for FY2021, which is 24.00% up from last year.
  • Per Ascendis Pharma A's latest filing, its Return on Invested Capital stood at 1.43% for Q3 2025, which was up 9.02% from 1.31% recorded in Q2 2025.
  • Over the past 5 years, Ascendis Pharma A's Return on Invested Capital peaked at 15.03% during Q3 2023, and registered a low of -2.14% during Q4 2023.
  • Moreover, its 3-year median value for Return on Invested Capital was 1.31% (2025), whereas its average is 1.69%.
  • In the last 5 years, Ascendis Pharma A's Return on Invested Capital spiked by 46bps in 2021 and then slumped by 1,354bps in 2024.
  • Quarterly analysis of 5 years shows Ascendis Pharma A's Return on Invested Capital stood at -0.46% in 2021, then plummeted by 102bps to -1.49% in 2022, then crashed by 65bps to -2.14% in 2023, then tumbled by 1,354bps to 1.50% in 2024, then dropped by 7bps to 1.43% in 2025.
  • Its Return on Invested Capital was 1.43% in Q3 2025, compared to 1.31% in Q2 2025 and -1.19% in Q1 2025.